-
1
-
-
0037123274
-
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Scientific review
-
N. Shaheen, and D.F. Ransohoff Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review JAMA 287 2002 1972 1981
-
(2002)
JAMA
, vol.287
, pp. 1972-1981
-
-
Shaheen, N.1
Ransohoff, D.F.2
-
3
-
-
13744258445
-
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
-
H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2005 142 146
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 142-146
-
-
Pohl, H.1
Welch, H.G.2
-
5
-
-
0036179390
-
Surveillance and survival in Barrett's adenocarcinomas: A population-based study
-
D.A. Corley, T.R. Levin, L.A. Habel, and et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640
-
(2002)
Gastroenterology
, vol.122
, pp. 633-640
-
-
Corley, D.A.1
Levin, T.R.2
Habel, L.A.3
-
6
-
-
85006179163
-
Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression
-
Apr 22
-
F. Kastelein, S.H. van Olphen, E.W. Steyerberg, and et al. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression Gut Epub 2015 Apr 22
-
(2015)
Gut Epub
-
-
Kastelein, F.1
Van Olphen, S.H.2
Steyerberg, E.W.3
-
7
-
-
84980528539
-
Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus
-
Aug 26
-
H.B. El-Serag, A.D. Naik, Z. Duan, and et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus Gut Epub 2015 Aug 26
-
(2015)
Gut Epub
-
-
El-Serag, H.B.1
Naik, A.D.2
Duan, Z.3
-
8
-
-
84905575282
-
Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: A population-based cohort study
-
R.E. Verbeek, M. Leenders, F.J. ten Kate, and et al. Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study Am J Gastroenterol 109 2014 1215 1222
-
(2014)
Am J Gastroenterol
, vol.109
, pp. 1215-1222
-
-
Verbeek, R.E.1
Leenders, M.2
Ten Kate, F.J.3
-
9
-
-
84880616361
-
Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas
-
D.A. Corley, K. Mehtani, C. Quesenberry, and et al. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas Gastroenterology 145 2013 312 319
-
(2013)
Gastroenterology
, vol.145
, pp. 312-319
-
-
Corley, D.A.1
Mehtani, K.2
Quesenberry, C.3
-
10
-
-
73549083853
-
Barrett's esophagus
-
P. Sharma Barrett's esophagus N Engl J Med 361 2009 2548 2556
-
(2009)
N Engl J Med
, vol.361
, pp. 2548-2556
-
-
Sharma, P.1
-
11
-
-
77954726942
-
Risk of malignant progression in patients with Barrett's oesophagus: A Dutch nationwide cohort study
-
P.J. de Jonge, M. Van Blankenstein, C.W. Looman, and et al. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study Gut 59 2010 1030 1036
-
(2010)
Gut
, vol.59
, pp. 1030-1036
-
-
De Jonge, P.J.1
Van Blankenstein, M.2
Looman, C.W.3
-
12
-
-
85045482804
-
Surveillance of Barrett's oesophagus: Exploring the uncertainty through systematic review, expert workshop and economic modelling
-
iii-iv
-
R. Garside, M. Pitt, M. Somerville, and et al. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling Health Technol Assess 10 2006 1 142 iii-iv
-
(2006)
Health Technol Assess
, vol.10
, pp. 1-142
-
-
Garside, R.1
Pitt, M.2
Somerville, M.3
-
13
-
-
84869199932
-
The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus
-
ASGE Standards of Practice Committee J.A. Evans, D.S. Early, N. Fukami, and et al. The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus Gastrointest Endosc 76 2012 1087 1094
-
(2012)
Gastrointest Endosc
, vol.76
, pp. 1087-1094
-
-
Evans, J.A.1
Early, D.S.2
Fukami, N.3
-
14
-
-
79960249713
-
Risk of malignant progression in Barrett's esophagus patients: Results from a large population-based study
-
S. Bhat, H.G. Coleman, F. Yousef, and et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study J Natl Cancer Inst 103 2011 1049 1057
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 1049-1057
-
-
Bhat, S.1
Coleman, H.G.2
Yousef, F.3
-
15
-
-
84885751662
-
Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: A systematic review and meta-analysis
-
S. Singh, A.N. Sharma, M.H. Murad, and et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 2013 1399 1412
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 1399-1412
-
-
Singh, S.1
Sharma, A.N.2
Murad, M.H.3
-
16
-
-
4544342836
-
Risk stratification of Barrett's esophagus: Updated prospective multivariate analysis
-
A.P. Weston, P. Sharma, S. Mathur, and et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis Am J Gastroenterol 99 2004 1657 1666
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1657-1666
-
-
Weston, A.P.1
Sharma, P.2
Mathur, S.3
-
17
-
-
84889668102
-
Barrett's oesophagus: Epidemiology, cancer risk and implications for management
-
P.J. de Jonge, M. van Blankenstein, W.M. Grady, and et al. Barrett's oesophagus: epidemiology, cancer risk and implications for management Gut 63 2014 191 202
-
(2014)
Gut
, vol.63
, pp. 191-202
-
-
De Jonge, P.J.1
Van Blankenstein, M.2
Grady, W.M.3
-
18
-
-
79960069342
-
Predictors for neoplastic progression in patients with Barrett's Esophagus: A prospective cohort study
-
M. Sikkema, C. Looman, E. Steyerberg, and et al. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study Am J Gastroenterol 106 2011 1231 1238
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 1231-1238
-
-
Sikkema, M.1
Looman, C.2
Steyerberg, E.3
-
19
-
-
28044459843
-
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: A prospective study
-
T.L. Vaughan, L.M. Dong, P.L. Blount, and et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study Lancet Oncol 6 2005 945 952
-
(2005)
Lancet Oncol
, vol.6
, pp. 945-952
-
-
Vaughan, T.L.1
Dong, L.M.2
Blount, P.L.3
-
20
-
-
84861722871
-
Aspirin and cancer risk: A quantitative review to 2011
-
C. Bosetti, V. Rosato, S. Gallus, and et al. Aspirin and cancer risk: a quantitative review to 2011 Ann Oncol 23 2012 1403 1415
-
(2012)
Ann Oncol
, vol.23
, pp. 1403-1415
-
-
Bosetti, C.1
Rosato, V.2
Gallus, S.3
-
21
-
-
84899918312
-
Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: A meta-analysis
-
S. Zhang, X.Q. Zhang, X.W. Ding, and et al. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis Br J Cancer 110 2014 2378 2388
-
(2014)
Br J Cancer
, vol.110
, pp. 2378-2388
-
-
Zhang, S.1
Zhang, X.Q.2
Ding, X.W.3
-
22
-
-
84859386286
-
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus
-
E.D. Kantor, L. Onstad, P.L. Blount, and et al. Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus Cancer Epidemiol Biomark Prevent 21 2012 456 461
-
(2012)
Cancer Epidemiol Biomark Prevent
, vol.21
, pp. 456-461
-
-
Kantor, E.D.1
Onstad, L.2
Blount, P.L.3
-
23
-
-
81855167480
-
Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus
-
F. Kastelein, M.C. Spaander, K. Biermann, and et al. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus Gastroenterology 141 2011 2000 2008
-
(2011)
Gastroenterology
, vol.141
, pp. 2000-2008
-
-
Kastelein, F.1
Spaander, M.C.2
Biermann, K.3
-
24
-
-
84864031678
-
Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma
-
I.L. Beales, I. Vardi, and L. Dearman Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma Eur J Gastroenterol Hepatol 24 2012 917 923
-
(2012)
Eur J Gastroenterol Hepatol
, vol.24
, pp. 917-923
-
-
Beales, I.L.1
Vardi, I.2
Dearman, L.3
-
25
-
-
77952837521
-
Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus
-
D.M. Nguyen, P. Richardson, and H.B. El-Serag Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus Gastroenterology 138 2010 2260 2266
-
(2010)
Gastroenterology
, vol.138
, pp. 2260-2266
-
-
Nguyen, D.M.1
Richardson, P.2
El-Serag, H.B.3
-
26
-
-
84878135553
-
Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: A systematic review and meta-analysis
-
S. Singh, A.G. Singh, P.P. Singh, and et al. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 2013 620 629
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 620-629
-
-
Singh, S.1
Singh, A.G.2
Singh, P.P.3
-
27
-
-
7044232109
-
Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus
-
H.B. El-Serag, T.V. Aguirre, S. Davis, and et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus Am J Gastroenterol 99 2004 1877 1883
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1877-1883
-
-
El-Serag, H.B.1
Aguirre, T.V.2
Davis, S.3
-
28
-
-
1942500137
-
Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
-
L.C. Hillman, L. Chiragakis, B. Shadbolt, and et al. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus Med J Australia 180 2004 387 391
-
(2004)
Med J Australia
, vol.180
, pp. 387-391
-
-
Hillman, L.C.1
Chiragakis, L.2
Shadbolt, B.3
-
29
-
-
14344253639
-
Barrett's oesophagus and oesophageal adenocarcinoma: How does acid interfere with cell proliferation and differentiation?
-
R. Fitzgerald Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut 54 2005 i21 i26
-
(2005)
Gut
, vol.54
, pp. i21-i26
-
-
Fitzgerald, R.1
-
30
-
-
84875365855
-
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus
-
F. Kastelein, M.C. Spaander, E.W. Steyerberg, and et al. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus Clin Gastroenterol Hepatol 11 2013 382 388
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 382-388
-
-
Kastelein, F.1
Spaander, M.C.2
Steyerberg, E.W.3
-
31
-
-
84904039736
-
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: A systematic review and meta-analysis
-
S. Singh, S.K. Garg, P.P. Singh, and et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis Gut 63 2014 1229 1237
-
(2014)
Gut
, vol.63
, pp. 1229-1237
-
-
Singh, S.1
Garg, S.K.2
Singh, P.P.3
-
32
-
-
0025856399
-
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
-
H. Jick, S.S. Jick, and L.E. Derby Validation of information recorded on general practitioner based computerised data resource in the United Kingdom BMJ 302 1991 766
-
(1991)
BMJ
, vol.302
, pp. 766
-
-
Jick, H.1
Jick, S.S.2
Derby, L.E.3
-
34
-
-
84882263647
-
Association of Barrett's esophagus with type II diabetes mellitus: Results from a large population-based case-control study
-
P.G. Iyer, B.J. Borah, H.C. Heien, and et al. Association of Barrett's esophagus with type II diabetes mellitus: results from a large population-based case-control study Clin Gastroenterol Hepatol 11 2013 1108 1114.e5
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 1108-1114e5
-
-
Iyer, P.G.1
Borah, B.J.2
Heien, H.C.3
-
35
-
-
3242658023
-
Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux
-
M. Solaymani-Dodaran, R. Logan, J. West, and et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut 53 2004 1070 1074
-
(2004)
Gut
, vol.53
, pp. 1070-1074
-
-
Solaymani-Dodaran, M.1
Logan, R.2
West, J.3
-
36
-
-
39349101029
-
Immortal time bias in pharmacoepidemiology
-
S. Suissa Immortal time bias in pharmacoepidemiology Am J Epidemiol 167 2008 492 499
-
(2008)
Am J Epidemiol
, vol.167
, pp. 492-499
-
-
Suissa, S.1
-
37
-
-
33947227921
-
Immortal time bias in observational studies of drug effects
-
S. Suissa Immortal time bias in observational studies of drug effects Pharmacoepidemiol Drug Safety 16 2007 241 249
-
(2007)
Pharmacoepidemiol Drug Safety
, vol.16
, pp. 241-249
-
-
Suissa, S.1
-
38
-
-
84871851757
-
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: A prospective study of Barrett's esophagus
-
S. Hardikar, L. Onstad, P.L. Blount, and et al. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus PloS One 8 2013 e52192
-
(2013)
PloS One
, vol.8
, pp. e52192
-
-
Hardikar, S.1
Onstad, L.2
Blount, P.L.3
-
39
-
-
0036784401
-
Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds
-
S. Zhu, Z. Wang, S. Heshka, and et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds Am J Clin Nutr 76 2002 743 749
-
(2002)
Am J Clin Nutr
, vol.76
, pp. 743-749
-
-
Zhu, S.1
Wang, Z.2
Heshka, S.3
-
40
-
-
84904039736
-
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: A systematic review and meta-analysis
-
S. Singh, S.K. Garg, P.P. Singh, and et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis Gut 63 2014 1229 1237
-
(2014)
Gut
, vol.63
, pp. 1229-1237
-
-
Singh, S.1
Garg, S.K.2
Singh, P.P.3
-
41
-
-
20444461067
-
Metformin and reduced risk of cancer in diabetic patients
-
J.M. Evans, L.A. Donnelly, A.M. Emslie-Smith, and et al. Metformin and reduced risk of cancer in diabetic patients BMJ 330 2005 1304 1305
-
(2005)
BMJ
, vol.330
, pp. 1304-1305
-
-
Evans, J.M.1
Donnelly, L.A.2
Emslie-Smith, A.M.3
-
42
-
-
75149179169
-
Metformin associated with lower cancer mortality in type 2 diabetes ZODIAC-16
-
G.W. Landman, N. Kleefstra, K.J. van Hateren, and et al. Metformin associated with lower cancer mortality in type 2 diabetes ZODIAC-16 Diabet Care 33 2010 322 326
-
(2010)
Diabet Care
, vol.33
, pp. 322-326
-
-
Landman, G.W.1
Kleefstra, N.2
Van Hateren, K.J.3
-
43
-
-
84924955218
-
Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus
-
665-72.e1-4
-
A. Chak, N.S. Buttar, N.R. Foster, and et al. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus Clin Gastroenterol Hepatol 13 2015 665-72.e1-4
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
-
-
Chak, A.1
Buttar, N.S.2
Foster, N.R.3
-
44
-
-
35148884884
-
Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk
-
C.J. Kelty, M.D. Gough, Q. Van Wyk, and et al. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk Scand J Gastroenterol 42 2007 1271 1274
-
(2007)
Scand J Gastroenterol
, vol.42
, pp. 1271-1274
-
-
Kelty, C.J.1
Gough, M.D.2
Van Wyk, Q.3
-
45
-
-
67649538054
-
Intestinal differentiation in metaplastic, non-goblet columnar epithelium in the esophagus
-
H.P. Hahn, P.L. Blount, K. Ayub, and et al. Intestinal differentiation in metaplastic, non-goblet columnar epithelium in the esophagus Am J Surg Pathol 33 2009 1006
-
(2009)
Am J Surg Pathol
, vol.33
, pp. 1006
-
-
Hahn, H.P.1
Blount, P.L.2
Ayub, K.3
-
46
-
-
65449135220
-
Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium
-
W. Liu, H. Hahn, R.D. Odze, and et al. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium Am J Gastroenterol 104 2009 816 824
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 816-824
-
-
Liu, W.1
Hahn, H.2
Odze, R.D.3
-
47
-
-
79961022952
-
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: A population-based study
-
K.W. Jung, N.J. Talley, Y. Romero, and et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study Am J Gastroenterol 106 2011 1447 1455
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 1447-1455
-
-
Jung, K.W.1
Talley, N.J.2
Romero, Y.3
|